Style | Citing Format |
---|---|
MLA | Aljurf M, et al.. "Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations." Hematology/ Oncology and Stem Cell Therapy, vol. 13, no. 1, 2020, pp. 7-16. |
APA | Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfandabaja M, Majhail N, Gerges U, Ali Hamidieh A, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, ... Niederwieser D (2020). Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations. Hematology/ Oncology and Stem Cell Therapy, 13(1), 7-16. |
Chicago | Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, et al.. "Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations." Hematology/ Oncology and Stem Cell Therapy 13, no. 1 (2020): 7-16. |
Harvard | Aljurf M et al. (2020) 'Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations', Hematology/ Oncology and Stem Cell Therapy, 13(1), pp. 7-16. |
Vancouver | Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, et al.. Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations. Hematology/ Oncology and Stem Cell Therapy. 2020;13(1):7-16. |
BibTex | @article{ author = {Aljurf M and Weisdorf D and Hashmi SK and Nassar A and Gluckman E and Mohty M and Rizzo D and Pasquini M and Hamadani M and Saber W and Hari P and Kharfandabaja M and Majhail N and Gerges U and Ali Hamidieh A and Hussain F and Elhaddad A and Mahmoud HK and Tbakhi A and Othman TB and Hamladji RM and Bekadja MA and Ahmed P and Bazarbachi A and Adil S and Alkindi S and Ladeb S and Dennison D and Patel M and Lu P and Quessar AE and Okamoto S and Atsuta Y and Alhejazi A and Ayas M and Ahmed SO and Novitzky N and Srivastava A and Seber A and Elsolh H and Ghavamzadeh A and Confer D and Kodera Y and Greinix H and Szer J and Horowitz M and Niederwieser D}, title = {Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations}, journal = {Hematology/ Oncology and Stem Cell Therapy}, volume = {13}, number = {1}, pages = {7-16}, year = {2020} } |
RIS | TY - JOUR AU - Aljurf M AU - Weisdorf D AU - Hashmi SK AU - Nassar A AU - Gluckman E AU - Mohty M AU - Rizzo D AU - Pasquini M AU - Hamadani M AU - Saber W AU - Hari P AU - Kharfandabaja M AU - Majhail N AU - Gerges U AU - Ali Hamidieh A AU - Hussain F AU - Elhaddad A AU - Mahmoud HK AU - Tbakhi A AU - Othman TB AU - Hamladji RM AU - Bekadja MA AU - Ahmed P AU - Bazarbachi A AU - Adil S AU - Alkindi S AU - Ladeb S AU - Dennison D AU - Patel M AU - Lu P AU - Quessar AE AU - Okamoto S AU - Atsuta Y AU - Alhejazi A AU - Ayas M AU - Ahmed SO AU - Novitzky N AU - Srivastava A AU - Seber A AU - Elsolh H AU - Ghavamzadeh A AU - Confer D AU - Kodera Y AU - Greinix H AU - Szer J AU - Horowitz M AU - Niederwieser D TI - Worldwide Network for Blood and Marrow Transplantation (Wbmt) Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries With Limited Resources (Part Ii): Clinical, Technical and Socio-Economic Considerations JO - Hematology/ Oncology and Stem Cell Therapy VL - 13 IS - 1 SP - 7 EP - 16 PY - 2020 ER - |